Supporting pharma and biotech teams in developing and delivering patient diagnostic programs. We provide an integrated solution by managing both the pharmaceutical and laboratory workstreams, allowing pharma teams to focus on key strategic decisions. We lead the design, launch, and optimisation of laboratory-based testing programs, from early strategy to real-world delivery.
—-
Design
Launch
Optimise
—-
Design genetic, biochemical and immunological patient testing initiatives that improve access, support diagnosis and generate meaningful program insights.
Develop biomarker and monitoring approaches that connect laboratory evidence with treatment outcomes.
Build laboratory-enabled studies with robust workflows, clear endpoints and fit-for-purpose data collection.
Strengthen an existing program or mobilise a new one with practical operational leadership.

Identify target patient population, generate evidence based gap analysis, integrate real world context and define measures of success.
Build the laboratory network, design the program, identify stakeholders, define target diagnostic journey and create a governance structure.
Translate the design into reality, manage timelines and get the program to launch readiness.
Continuous monitoring of program, track program performance, identify barriers and optimise for quality, access and impact.

Principal Consultant – NBC Diagnostics Consultants (1 year)
International Diagnostics Lead – Alnylam Pharmaceuticals (4 years)
Global Diagnostics Lead – BioMarin Pharmaceuticals (4 years)
Lecturer – Nottingham Trent University (3 years)
Project Manager – Oxford Global (1 year)
Technical Assistant – Laboratory, Heartlands Hospital, NHS (3 years)
Contact us using the below form
© Copyright 2026 Nermin BioChem Limited (NBC Diagnostics)